These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 30312728)

  • 1. Natural compound Tetrocarcin-A downregulates Junctional Adhesion Molecule-A in conjunction with HER2 and inhibitor of apoptosis proteins and inhibits tumor cell growth.
    Vellanki SH; Cruz RGB; Jahns H; Hudson L; Sette G; Eramo A; Hopkins AM
    Cancer Lett; 2019 Jan; 440-441():23-34. PubMed ID: 30312728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic Tetrocarcin-A Down-regulates JAM-A, IAPs and Induces Apoptosis in Triple-negative Breast Cancer Models.
    Vellanki SH; Cruz RGB; Richards CE; Smith YE; Hudson L; Jahns H; Hopkins AM
    Anticancer Res; 2019 Mar; 39(3):1197-1204. PubMed ID: 30842150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cleavage of the extracellular domain of junctional adhesion molecule-A is associated with resistance to anti-HER2 therapies in breast cancer settings.
    Leech AO; Vellanki SH; Rutherford EJ; Keogh A; Jahns H; Hudson L; O'Donovan N; Sabri S; Abdulkarim B; Sheehan KM; Kay EW; Young LS; Hill ADK; Smith YE; Hopkins AM
    Breast Cancer Res; 2018 Nov; 20(1):140. PubMed ID: 30458861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Junctional adhesion molecule-A is co-expressed with HER2 in breast tumors and acts as a novel regulator of HER2 protein degradation and signaling.
    Brennan K; McSherry EA; Hudson L; Kay EW; Hill AD; Young LS; Hopkins AM
    Oncogene; 2013 May; 32(22):2799-804. PubMed ID: 22751120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTK6 inhibition promotes apoptosis of Lapatinib-resistant Her2(+) breast cancer cells by inducing Bim.
    Park SH; Ito K; Olcott W; Katsyv I; Halstead-Nussloch G; Irie HY
    Breast Cancer Res; 2015 Jun; 17(1):86. PubMed ID: 26084280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Transcriptional Link between HER2, JAM-A and FOXA1 in Breast Cancer.
    Cruz RGB; Madden SF; Brennan K; Hopkins AM
    Cells; 2022 Feb; 11(4):. PubMed ID: 35203384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disulfiram targets cancer stem-like properties and the HER2/Akt signaling pathway in HER2-positive breast cancer.
    Kim JY; Cho Y; Oh E; Lee N; An H; Sung D; Cho TM; Seo JH
    Cancer Lett; 2016 Aug; 379(1):39-48. PubMed ID: 27238567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-β1 attenuates junctional adhesion molecule-A and contributes to breast cancer cell invasion.
    Wang Y; Lui WY
    Eur J Cancer; 2012 Dec; 48(18):3475-87. PubMed ID: 22647687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis and inactivation of the PI3-kinase pathway by tetrocarcin A in breast cancers.
    Nakajima H; Sakaguchi K; Fujiwara I; Mizuta M; Tsuruga M; Magae J; Mizuta N
    Biochem Biophys Res Commun; 2007 Apr; 356(1):260-5. PubMed ID: 17350598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential utility of acetyltanshinone IIA in the treatment of HER2-overexpressed breast cancer: Induction of cancer cell death by targeting apoptotic and metabolic signaling pathways.
    Guerram M; Jiang ZZ; Yousef BA; Hamdi AM; Hassan HM; Yuan ZQ; Luo HW; Zhu X; Zhang LY
    Oncotarget; 2015 Sep; 6(26):21865-77. PubMed ID: 26068969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JAM-A overexpression is related to disease progression in diffuse large B-cell lymphoma and downregulated by lenalidomide.
    Xu PP; Sun YF; Fang Y; Song Q; Yan ZX; Chen Y; Jiang XF; Fei XC; Zhao Y; Leboeuf C; Li B; Wang CF; Janin A; Wang L; Zhao WL
    Sci Rep; 2017 Aug; 7(1):7433. PubMed ID: 28785100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer cell migration is regulated through junctional adhesion molecule-A-mediated activation of Rap1 GTPase.
    McSherry EA; Brennan K; Hudson L; Hill AD; Hopkins AM
    Breast Cancer Res; 2011 Mar; 13(2):R31. PubMed ID: 21429211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells.
    Asanuma H; Torigoe T; Kamiguchi K; Hirohashi Y; Ohmura T; Hirata K; Sato M; Sato N
    Cancer Res; 2005 Dec; 65(23):11018-25. PubMed ID: 16322251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of junctional adhesion molecule-A is a contributing factor for breast cancer cell invasion.
    Naik MU; Naik TU; Suckow AT; Duncan MK; Naik UP
    Cancer Res; 2008 Apr; 68(7):2194-203. PubMed ID: 18381425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Junctional adhesion molecule-A promotes proliferation and inhibits apoptosis of gastric cancer.
    Ikeo K; Oshima T; Shan J; Matsui H; Tomita T; Fukui H; Watari J; Miwa H
    Hepatogastroenterology; 2015; 62(138):540-5. PubMed ID: 25916097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-145-dependent targeting of junctional adhesion molecule A and modulation of fascin expression are associated with reduced breast cancer cell motility and invasiveness.
    Götte M; Mohr C; Koo CY; Stock C; Vaske AK; Viola M; Ibrahim SA; Peddibhotla S; Teng YH; Low JY; Ebnet K; Kiesel L; Yip GW
    Oncogene; 2010 Dec; 29(50):6569-80. PubMed ID: 20818426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multilayered proteomics reveals that JAM-A promotes breast cancer progression via regulation of amino acid transporter LAT1.
    Magara K; Takasawa A; Takasawa K; Aoyama T; Ota M; Kyuno D; Ono Y; Murakami T; Yamamoto S; Nakamori Y; Nakahashi N; Kutomi G; Takemasa I; Hasegawa T; Osanai M
    Cancer Sci; 2024 Sep; 115(9):3153-3168. PubMed ID: 38943512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulation of junctional adhesion molecule-A via p63/GATA-3 in head and neck squamous cell carcinoma.
    Kakuki T; Kurose M; Takano K; Kondoh A; Obata K; Nomura K; Miyata R; Kaneko Y; Konno T; Takahashi S; Hatakeyama T; Kohno T; Himi T; Kojima T
    Oncotarget; 2016 Jun; 7(23):33887-900. PubMed ID: 27036044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low junctional adhesion molecule A expression correlates with poor prognosis in gastric cancer.
    Huang JY; Xu YY; Sun Z; Wang ZN; Zhu Z; Song YX; Luo Y; Zhang X; Xu HM
    J Surg Res; 2014 Dec; 192(2):494-502. PubMed ID: 25033702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Hsp90 inhibitor FW-04-806 displays potent antitumor effects in HER2-positive breast cancer cells as a single agent or in combination with lapatinib.
    Huang W; Wu QD; Zhang M; Kong YL; Cao PR; Zheng W; Xu JH; Ye M
    Cancer Lett; 2015 Jan; 356(2 Pt B):862-71. PubMed ID: 25449780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.